Impact of advances in physiology, biochemistry, and molecular biology on pulmonary disease in neonates

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 4 II SUPPL., 1998, Pages

  Whitsett, Jeffrey A ^a   Stahlman, Mildred T ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT;

ACID BASE BALANCE; BIOCHEMISTRY; FETUS LUNG MATURATION; GENETICS; HOST RESISTANCE; HUMAN; LUNG DISEASE; MOLECULAR BIOLOGY; NEWBORN; NONHUMAN; NUTRITIONAL SUPPORT; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SUBSTITUTION THERAPY;

EID: 0031946409     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.4.nhlb1-2     Document Type: Review

References (16)

1. James, L. S., I. M. Weisbrot, and C. E. Prince. 1958. The acid-base status of human infants in regulating to birth asphyxia and onset of respiration. J. Pediatr. 52:379.
2. Burri, P. 1985. Development and growth of the human lung. In Handbook and Physiology, Vol. 1. American Physiological Society, Bethesda, MD. 1-46.
3. Liggins, G. C. 1969. Premature delivery of foetal Iamb infused with glucocorticoids. J. Endocrinol. 45:515-523.
4. Liggins, G. C., and R. N. Howie. 1972. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50:515-524.
5. Jobe, A. H., B. R. Mitchell, and J. H. Gunkel. 1993. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am. J. Obstet. Gynecol. 168:508-513.
6. Pattle, R. E. 1955. Properties, function and origin of the alveolar lining layer. Nature 175:1125-1126.
7. Clements, J. A. 1962. Surface phenomena in relation to pulmonary function. The Physiologist 5:11.
8. Avery, M. E., and J. Mead. 1959. Surface properties in relation to atelectasis and hyaline membrane disease. Am. J. Dis. Child. 97:517-523.
9. Gluck, L., and M. Kulovich. 1973. Lecithin/sphingomyelin ratios in amniotic fluid in normal and abnormal pregnancy. Am. J. Obstet. Gynecol. 115:539-546.
10. Whitsett, J. A., B. L. Ohning, G. Ross, J. Meuth, T. Weaver, B. A. Holm, D. L. Shapiro, and R. H. Notter. 1986. Hydrophobic surfactant-associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used for replacement therapy. Pediatr. Res. 20:460-467.
11. Fujiwara, T., H. Maeta, S. Chida, T. Morita, Y. Watabe, and T. Abe. 1980. Artificial surfactant therapy in hyaline-membrane disease. Lancet 1:55-59.
12. Soll, R. F., T. A. Merritt, and M. Hallman. 1995. Surfactant in the prevention and treatment of respiratory distress syndrome. In B. R. Boynton, W. A. Carlo, and A. H. Jobe, editors. New Therapies for Neonatal Respiratory Failure: A Physiological Approach. Cambridge University Press, New York. 49-80.
13. Kuroki, Y., and D. R. Voelker. 1994. Pulmonary surfactant proteins. J. Biol. Chem. 42:25943-25946.
14. Clark, J. C., S. E. Wert, C. J. Bachurski, M. T. Stahlman, B. R. Stripp, T. E. Weaver, and J. A. Whitsett. 1995. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc. Natl. Acad. Sci. U.S.A. 92:7794-7798.
15. Nogee, L. M., D. E. deMello, L. P. Dehner, and H. R. Colten. 1993. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N. Engl. J. Med. 328:406-410.
16. Whitsett, J. A., L. M. Nogee, T. E. Weaver, and A. D. Horowitz. 1995. Human surfactant protein B structure, function, regulation and genetic disease. Physiological Reviews 75:749-757.